MiR-218 Sensitizes Glioma Cells to Apoptosis and Inhibits Tumorigenicity by Regulating ECOP-mediated Suppression of NF-κB Activity

Overview

Journal Neuro Oncol

Publisher Oxford University Press

Specialties Neurology
Oncology

Date 2012 Dec 18

PMID 23243056

Citations 45

Authors

Hongping Xia

YuKui Yan

Minghua Hu

Yaxian Wang

Yongsheng Wang

Yi Dai

Jianming Chen

Guangfu Di

Xiaobing Chen

Xiaochun Jiang

Affiliations

Soon will be listed here.

Abstract

Introduction: Malignant gliomas are the most common and deadly primary brain tumors in adults. Increasing evidence has indicated that microRNAs (miRNAs) have an influence on the regulation of apoptotic cell signaling. Downregulation of miRNA 218 (miR-218) has been indicated in human glioma specimens. Here, we investigate the function of miR-218 in apoptosis and tumor growth of glioma cells.

Methods: The expression of miR-218 was detected by real-time quantitative reverse transcriptase PCR. The effects of miR-218 on glioma cell proliferation and tumorigenicity were investigated by in vitro clonogenicity and in vivo xenograft assay. Apoptosis was evaluated by flow cytometric analysis and assay by terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling. The downstream targets of miR-218 were identified by bioinformatics analysis and further validated by Western blot and luciferase reporter assay.

Results: Overexpression of miR-218 induces glioma cell apoptosis and inhibits glioma cell viability, proliferation, and tumorigenicity. Epidermal growth factor receptor-coamplified and overexpressed protein (ECOP) was identified as a functional downstream target of miR-218, which can regulate transcriptional activity of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and associated with apoptotic response. Ectopic expression of ECOP rescued the glioma cells from miR-218-induced apoptosis and increased NF-κB activity.

Conclusion: These results suggest that miR-218 sensitizes glioma cells to apoptosis by regulating ECOP-mediated suppression of NF-κB activity, which may provide novel opportunities for glioma therapy.

Citing Articles

Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.

Khalafizadeh A, Hashemizadegan S, Shokri F, Bakhshinejad B, Jabbari K, Motavaf M J Cell Mol Med. 2024; 28(7):e18197.

PMID: 38506091 PMC: 10951891. DOI: 10.1111/jcmm.18197.

MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease.

Wang D, Gao H, Qin Q, Li J, Zhao J, Qu Y J Transl Med. 2024; 22(1):63.

PMID: 38229084 PMC: 10792813. DOI: 10.1186/s12967-024-04881-w.

miR-218: A Stress-Responsive Epigenetic Modifier.

Schell G, Roy B, Prall K, Dwivedi Y Noncoding RNA. 2022; 8(4).

PMID: 35893238 PMC: 9326663. DOI: 10.3390/ncrna8040055.

MiRNA-218 inhibits cell proliferation, migration and invasion by targeting Runt-related transcription factor 2 (Runx2) in human osteosarcoma cells.

Guo Q, Ma J, Wu J Regen Ther. 2022; 18:508-515.

PMID: 34977284 PMC: 8668442. DOI: 10.1016/j.reth.2021.11.003.

The Role of Non-coding RNAs in the Pathogenesis of Glial Tumors.

Kovalenko T, Larionova T, Antipova N, Shakhparonov M, Pavlyukov M Acta Naturae. 2021; 13(3):38-51.

PMID: 34707896 PMC: 8526181. DOI: 10.32607/actanaturae.11270.

References

Roth P, Wischhusen J, Happold C, Chandran P, Hofer S, Eisele G . A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem. 2011; 118(3):449-57. DOI: 10.1111/j.1471-4159.2011.07307.x. View

Rao S, Santosh V, Somasundaram K . Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol. 2010; 23(10):1404-17. DOI: 10.1038/modpathol.2010.135. View

Van Meir E, Hadjipanayis C, Norden A, Shu H, Wen P, Olson J . Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010; 60(3):166-93. PMC: 2888474. DOI: 10.3322/caac.20069. View

Bader A, Brown D, Winkler M . The promise of microRNA replacement therapy. Cancer Res. 2010; 70(18):7027-30. PMC: 2940943. DOI: 10.1158/0008-5472.CAN-10-2010. View

Xu B, Hsu P, Karayiorgou M, Gogos J . MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol Dis. 2012; 46(2):291-301. PMC: 3329786. DOI: 10.1016/j.nbd.2012.02.016. View

Bartel D . MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215-33. PMC: 3794896. DOI: 10.1016/j.cell.2009.01.002. View

Clarke J, Butowski N, Chang S . Recent advances in therapy for glioblastoma. Arch Neurol. 2010; 67(3):279-83. DOI: 10.1001/archneurol.2010.5. View

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

Long J, Lahiri D . Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders. Exp Neurol. 2012; 235(2):402-18. PMC: 3811031. DOI: 10.1016/j.expneurol.2011.12.043. View

10.

Park S, James C . ECop (EGFR-coamplified and overexpressed protein), a novel protein, regulates NF-kappaB transcriptional activity and associated apoptotic response in an IkappaBalpha-dependent manner. Oncogene. 2005; 24(15):2495-502. DOI: 10.1038/sj.onc.1208496. View

11.

Jovanovic M, Hengartner M . miRNAs and apoptosis: RNAs to die for. Oncogene. 2006; 25(46):6176-87. DOI: 10.1038/sj.onc.1209912. View

12.

Baras A, Yu Y, Filtz M, Kim B, Moskaluk C . Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification. Oncogene. 2009; 28(32):2919-24. DOI: 10.1038/onc.2009.150. View

13.

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

14.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

15.

Godlewski J, Nowicki M, Bronisz A, Williams S, Otsuki A, Nuovo G . Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008; 68(22):9125-30. DOI: 10.1158/0008-5472.CAN-08-2629. View

16.

Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View

17.

Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese G, Ciafre S . miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem. 2007; 282(32):23716-24. DOI: 10.1074/jbc.M701805200. View

18.

Silber J, Lim D, Petritsch C, Persson A, Maunakea A, Yu M . miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008; 6:14. PMC: 2443372. DOI: 10.1186/1741-7015-6-14. View

19.

Park D, Sathornsumetee S, Rich J . Medical oncology: treatment and management of malignant gliomas. Nat Rev Clin Oncol. 2010; 7(2):75-7. DOI: 10.1038/nrclinonc.2009.221. View

20.

Pang J, Kwok W, Chen Z, Ng H . Oncogenic role of microRNAs in brain tumors. Acta Neuropathol. 2009; 117(6):599-611. DOI: 10.1007/s00401-009-0525-0. View